ENDOTHELIN-1 ACTIVATION IS IMPAIRED IN BLADDER AND CORPORAL SMOOTH MUSCLE OF CAVEOLIN-1-KNOCKOUT MICE

2009 ◽  
Vol 181 (4S) ◽  
pp. 302-302
Author(s):  
Christian Gratzke ◽  
Christian G Stief ◽  
Michael P. Lisanti ◽  
Petter Hedlund ◽  
Karl-Erik Andersson ◽  
...  
2006 ◽  
Vol 74 (1) ◽  
pp. 152-159 ◽  
Author(s):  
Ghada S. Hassan ◽  
Shankar Mukherjee ◽  
Fnu Nagajyothi ◽  
Louis M. Weiss ◽  
Stefka B. Petkova ◽  
...  

ABSTRACT Trypanosoma cruzi infection causes cardiomyopathy and vasculopathy. Previous studies have demonstrated that infection of human umbilical vein endothelial and smooth muscle cells resulted in activation of extracellular signal-regulated kinase (ERK). In the present study, smooth muscle cells were infected with trypomastigotes, and immunoblot analysis revealed an increase in the expression of cyclin D1 and proliferating cell nuclear antigen (PCNA), important mediators of smooth muscle cell proliferation. Interestingly, after infection, the expression of caveolin-1 was reduced in both human umbilical vein endothelial cells and smooth muscle cells. Immunoblot and immunohistochemical analyses of lysates of carotid arteries obtained from infected mice revealed increased expression of PCNA, cyclin D1, its substrate, phospho-Rb (Ser780), and phospho-ERK1/2. The expression of the cyclin-dependent kinase inhibitor p21 Cip1/Waf1 , caveolin-1, and caveolin-3 was reduced in carotid arteries obtained from infected mice. There was an increase in the abundance of pre-pro-endothelin-1 mRNA in the carotid artery and aorta from infected mice. The ETA receptor was also elevated in infected arteries. ERK activates endothelin-1, which in turn exerts positive feedback activating ERK, and cyclin D1 is a downstream target of both endothelin-1 and ERK. There was significant incorporation of bromodeoxyuridine into smooth muscle cell DNA when treatment was with conditioned medium obtained from infected endothelial cells. Taken together, these data suggest that T. cruzi infection stimulates smooth muscle cell proliferation and is likely a result of the upregulation of the ERK-cyclin D1-endothelin-1 pathway.


Hypertension ◽  
1995 ◽  
Vol 25 (4) ◽  
pp. 744-747 ◽  
Author(s):  
Takeshi Nakahashi ◽  
Keisuke Fukuo ◽  
Takuo Inoue ◽  
Shigeto Morimoto ◽  
Shigeki Hata ◽  
...  

2021 ◽  
Vol 27 (Supplement_1) ◽  
pp. S34-S35
Author(s):  
Jiannan Li ◽  
Ilyssa Gordon ◽  
Dina Dejanovic ◽  
Sinan Lin ◽  
Jie Wang ◽  
...  

Abstract Background Intestinal fibrosis is a severe complication of inflammatory bowel diseases (IBD) leading to intestinal strictures and need for surgery. No effective anti-fibrotic therapy is available. Cadherin-11 (Cad-11) is an adherens junction protein, which is upregulated in rheumatoid arthritis (RA), idiopathic pulmonary fibrosis (IPF) and skin fibrosis. Inhibition of cadherin-11 has shown beneficial effects in RA and IPF animal models. A phase II clinical trial of cadherin-11 inhibition in RA has shown a good safety profile. Our aim was to evaluate the expression levels and function of Cad-11 in IBD patients using intestinal tissues, primary human intestinal cells, and the murine dextran sulfate sodium (DSS)-induced chronic colitis model. Methods IBD (Crohn’s disease (CD) n=20; Ulcerative colitis (UC) (n=10) and control (n=10) full thickness resected intestinal tissues were procured from adults in accordance with IRB approval. Protein and mRNA were extracted for western blot (WB) and quantitative polymerase chain reaction (qPCR). Distribution of Cad-11 was evaluated by immunofluorescence (IF) and RNA hybridization in frozen and formalin-fixed paraffin-embedded (FFPE) tissue sections, respectively. Primary human intestinal myofibroblasts (HIMF) were used in functional experiments. Recombinant human Fc and Cad-11 extracellular domain (hCAD-11-Fc) was used as activator and siRNA as inhibitor of Cad-11 in HIMF. Murine chronic colitis was induced in wildtype BALB/c mice and cadherin-11 knockout mice by DSS. Anti-Cad-11 monoclonal antibody (H1M1) was used for the treatment of BALB/c mouse colitis. Results Increased gene and protein expression levels of Cad-11 were found in intestinal full thickness IBD tissue compared to controls (45-fold, p<0.01). Cad-11 colocalized with alpha smooth muscle actin (α-SMA) (Figure 1), indicating that Cad-11 is selectively expressed in intestinal myofibroblasts and smooth muscle cells. Among all the primary human intestinal cells, Cad-11 was expressed exclusively in HIMF and HIMC cells. Level of Cad-11 was increased in IBD HIMFs compared to non-IBD controls, and increased upon stimulation with TNF-α, IL-1β, b-FGF and TGF-β (all p<0.01). Knocking down Cad-11 with siRNA decreased FN expression, while hCAD-11-Fc increased the expression FN in a dose- and time-dependent manner as well as the proliferation of HIMF. Upon treatment with H1M1 antibody, DSS-treated mice showed lower clinical scores and weight loss compared to control mice (p<0.001. Figure 2), as well as less FN expression (p<0.001). Cadherin-11 knockout mice also showed lower clinical scores and weight loss compared to wild type mice (p<0.001). Conclusions Cad-11 expression is increased in CD stricture tissues and its blockade reduces profibrotic effects in HIMF in vitro. Inhibition of Cad-11 in vivo reduces clinical severity and fibrosis of experimental colitis.


1998 ◽  
Vol 19 (5) ◽  
pp. 805-811 ◽  
Author(s):  
Masayuki Nara ◽  
Tsukasa Sasaki ◽  
Sanae Shimura ◽  
Takako Oshiro ◽  
Toshiya Irokawa ◽  
...  

1994 ◽  
Vol 7 (6) ◽  
pp. 409-413 ◽  
Author(s):  
J.E. Nally ◽  
R.A. Clayton ◽  
M.J.O. Wakelam ◽  
N.C. Thomson ◽  
J.C. McGrath

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Martin Hennenberg ◽  
Alice C. Acevedo ◽  
Alexander Tamalunas ◽  
Yiming Wang ◽  
Beata Rutz ◽  
...  

2002 ◽  
Vol 99 (17) ◽  
pp. 11375-11380 ◽  
Author(s):  
Y.-Y. Zhao ◽  
Y. Liu ◽  
R.-V. Stan ◽  
L. Fan ◽  
Y. Gu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document